407 related articles for article (PubMed ID: 26253381)
1. IL-27-induced modulation of autoimmunity and its therapeutic potential.
Meka RR; Venkatesha SH; Dudics S; Acharya B; Moudgil KD
Autoimmun Rev; 2015 Dec; 14(12):1131-1141. PubMed ID: 26253381
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
3. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
Wu D; Wang J; Pae M; Meydani SN
Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
Astry B; Venkatesha SH; Moudgil KD
Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
[TBL] [Abstract][Full Text] [Related]
5. IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.
Visperas A; Do JS; Bulek K; Li X; Min B
Mucosal Immunol; 2014 May; 7(3):625-33. PubMed ID: 24129161
[TBL] [Abstract][Full Text] [Related]
6. Aetiopathogenesis of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
[TBL] [Abstract][Full Text] [Related]
7. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of IL-35 in inflammatory autoimmune diseases.
Su LC; Liu XY; Huang AF; Xu WD
Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
[TBL] [Abstract][Full Text] [Related]
9. Regulatory role of PI16 in autoimmune arthritis and intestinal inflammation: implications for Treg cell differentiation and function.
Sun Y; Lin S; Wang H; Wang L; Qiu Y; Zhang F; Hao N; Wang F; Tan W
J Transl Med; 2024 Apr; 22(1):327. PubMed ID: 38566233
[TBL] [Abstract][Full Text] [Related]
10. CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.
Mariño E; Villanueva J; Walters S; Liuwantara D; Mackay F; Grey ST
Diabetes; 2009 Jul; 58(7):1568-77. PubMed ID: 19336675
[TBL] [Abstract][Full Text] [Related]
11. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
Stadhouders R; Lubberts E; Hendriks RW
J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.
André S; Tough DF; Lacroix-Desmazes S; Kaveri SV; Bayry J
Am J Pathol; 2009 May; 174(5):1575-87. PubMed ID: 19349365
[TBL] [Abstract][Full Text] [Related]
13. The
Gorman JA; Hundhausen C; Kinsman M; Arkatkar T; Allenspach EJ; Clough C; West SE; Thomas K; Eken A; Khim S; Hale M; Oukka M; Jackson SW; Cerosaletti K; Buckner JH; Rawlings DJ
Front Immunol; 2019; 10():44. PubMed ID: 30740104
[TBL] [Abstract][Full Text] [Related]
14. Naringenin Modifies the Development of Lineage-Specific Effector CD4
Wang J; Niu X; Wu C; Wu D
Front Immunol; 2018; 9():2267. PubMed ID: 30327657
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and immunobiology of IL-21 in autoimmunity.
Long D; Chen Y; Wu H; Zhao M; Lu Q
J Autoimmun; 2019 May; 99():1-14. PubMed ID: 30773373
[TBL] [Abstract][Full Text] [Related]
16. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
[TBL] [Abstract][Full Text] [Related]
18. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.
Neurath MF; Finotto S
Cytokine Growth Factor Rev; 2011 Apr; 22(2):83-9. PubMed ID: 21377916
[TBL] [Abstract][Full Text] [Related]
19. IL-27 and autoimmune rheumatologic diseases: The good, the bad, and the ugly.
Shahi A; Afzali S; Salehi S; Aslani S; Mahmoudi M; Jamshidi A; Amirzargar A
Int Immunopharmacol; 2020 Jul; 84():106538. PubMed ID: 32361567
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cell effects on T-cell effector pathways.
Duffy MM; Ritter T; Ceredig R; Griffin MD
Stem Cell Res Ther; 2011 Aug; 2(4):34. PubMed ID: 21861858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
